Schedule 13D ownership disclosure
INNOVATE BIOPHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45782F105
Event date: 2021-04-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-21-000407
- Form type
- SC 13D
- Filer
- 9 METERS BIOPHARMA, INC.
- CIK
- CIK 1551986
- Filed
- Apr 07, 2021
- Reporting period
- Apr 05, 2021
- Description
- Schedule 13D beneficial ownership